Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 206 entries
View as:

A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances

Phase: N/A Priority: Normal
NCT ID: NCT04155801 Org: User:
Start: 10/11/19 End: 02/14/20 Due: 02/14/21

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05976802 Org: User:
Start: 06/30/24 End: 06/30/25 Due: 06/30/26

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02785185 Org: User:
Start: 06/30/16 End: 01/31/17 Due: 01/31/18

(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00679432 Org: User:
Start: 06/30/08 End: 06/30/10 Due: 06/30/11

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT03063489 Org: User:
Start: 02/28/15 End: 07/31/15 Due: 07/31/16

Open-Label Treatment Extension of Protocol MNTX 301

Phase: N/A Priority: Normal
NCT ID: NCT01367600 Org: User:
Start: 02/28/03 End: 02/28/05 Due: 02/28/06

Study Evaluating MOA-728 Administered in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT00427258 Org: User:
Start: 01/31/10 End: - Due: -

Open-Label Treatment Extension of Protocol MNTX 302

Phase: N/A Priority: Normal
NCT ID: NCT01367613 Org: User:
Start: 03/31/04 End: 01/31/06 Due: 01/31/07

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00348010 Org: User:
Start: 11/30/00 End: 07/31/01 Due: 07/31/02

Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)

Phase: N/A Priority: Normal
NCT ID: NCT01532648 Org: User:
Start: 01/27/12 End: 10/02/13 Due: 10/02/14

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT03120520 Org: User:
Start: 01/31/17 End: 09/07/18 Due: 09/07/19

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04214639 Org: User:
Start: 01/17/20 End: 01/18/21 Due: 01/18/22

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

Phase: N/A Priority: Normal
NCT ID: NCT00360932 Org: User:
Start: 10/31/05 End: 08/31/11 Due: 08/31/12

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02462070 Org: User:
Start: 08/11/15 End: 12/01/16 Due: 12/01/17

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01367522 Org: User:
Start: 03/31/04 End: 07/31/04 Due: 07/31/05

Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)

Phase: N/A Priority: Normal
NCT ID: NCT03596905 Org: User:
Start: 06/30/18 End: 12/31/23 Due: 12/31/24

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT05098028 Org: User:
Start: 03/22/22 End: 09/04/23 Due: 09/04/24

Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT00983736 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05071716 Org: User:
Start: 04/07/22 End: 09/30/25 Due: 09/30/26

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Phase: N/A Priority: Normal
NCT ID: NCT00230490 Org: User:
Start: 06/30/05 End: 05/31/07 Due: 05/31/08

Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01367574 Org: User:
Start: 04/30/02 End: 05/31/03 Due: 05/31/04

A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Phase: N/A Priority: Normal
NCT ID: NCT04149587 Org: User:
Start: 09/30/19 End: 03/30/22 Due: 03/30/23

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

Phase: N/A Priority: Normal
NCT ID: NCT01367535 Org: User:
Start: 03/31/06 End: 08/31/06 Due: 08/31/07

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02514577 Org: User:
Start: 11/07/15 End: 05/01/17 Due: 05/01/18

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Phase: N/A Priority: Normal
NCT ID: NCT01008410 Org: User:
Start: 11/17/09 End: 04/29/13 Due: 04/29/14